{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:36:40Z","timestamp":1792676200102,"version":"4.5.0"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2018.00004","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T04:16:26Z","timestamp":1517458586000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Parvovirus B19: What Is the Relevance in Transfusion Medicine?"],"prefix":"10.3389","volume":"5","author":[{"given":"David","family":"Juhl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Hennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0140-6736(75)91074-0","article-title":"Parvovirus-like particles in human sera","volume":"1","author":"Cossart","year":"1975","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000322190","article-title":"Parvovirus B19 \u2013 revised","volume":"37","author":"Bl\u00fcmel","year":"2010","journal-title":"Transfus Med Hemother"},{"key":"B3","doi-asserted-by":"publisher","first-page":"9658","DOI":"10.1128\/JVI.00684-10","article-title":"Advances in human B19 erythrovirus biology","volume":"84","author":"Servant-Delmas","year":"2010","journal-title":"J Virol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1056\/NEJMra030840","article-title":"Parvovirus B19","volume":"350","author":"Young","year":"2004","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1126\/science.8211117","article-title":"Erythrocyte P antigen: cellular receptor for B19 parvovirus","volume":"262","author":"Brown","year":"1993","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1534-5807(01)00031-4","article-title":"A viral phospholipase A2 is required for parvovirus infectivity","volume":"1","author":"Z\u00e1dori","year":"2001","journal-title":"Dev Cell"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1093\/infdis\/167.5.1034","article-title":"Candidate recombinant vaccine for human B19 parvovirus","volume":"167","author":"Bansal","year":"1993","journal-title":"J Infect Dis"},{"key":"B8","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1128\/JVI.67.6.3004-3009.1993","article-title":"Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions","volume":"67","author":"Saikawa","year":"1993","journal-title":"J Virol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/S0140-6736(83)92152-9","article-title":"Human parvovirus, the cause of erythema infectiosum (fifth disease)?","volume":"1","author":"Anderson","year":"1983","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1172\/JCI112978","article-title":"Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19)","volume":"79","author":"Potter","year":"1987","journal-title":"J Clin Invest"},{"key":"B11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s002770050477","article-title":"Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease","volume":"78","author":"Osaki","year":"1999","journal-title":"Ann Hematol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1136\/adc.87.5.436","article-title":"Aplastic anaemia associated with parvovirus B19 infection","volume":"87","author":"Qian","year":"2002","journal-title":"Arch Dis Child"},{"key":"B13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00296-006-0227-z","article-title":"A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infection","volume":"27","author":"Ideguchi","year":"2007","journal-title":"Rheumatol Int"},{"key":"B14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/infdis\/152.2.257","article-title":"Experimental parvoviral infection in humans","volume":"152","author":"Anderson","year":"1985","journal-title":"J Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1182\/blood-2009-06-225706","article-title":"A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion","volume":"114","author":"Kleinman","year":"2009","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1182\/blood-2009-09-239939","article-title":"Transfused B19V: B-nign, B-ware, B-gone?","volume":"114","author":"Klein","year":"2009","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1128\/JCM.24.4.522-526.1986","article-title":"Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay","volume":"24","author":"Anderson","year":"1986","journal-title":"J Clin Microbiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1017\/S0950268807009958","article-title":"Seroprevalence of parvovirus B19 in the German population","volume":"136","author":"R\u00f6hrer","year":"2008","journal-title":"Epidemiol Infect"},{"key":"B19","first-page":"25","article-title":"Seroprevalence of anti-human parvovirus B19 antibodies in a sample of blood donors in Galicia","volume":"16","author":"Mata Reb\u00f3n","year":"1998","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"B20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.mjafi.2012.11.009","article-title":"Seroprevalence of human parvovirus B19 in healthy blood donors","volume":"69","author":"Kumar","year":"2013","journal-title":"Med J Armed Forces India"},{"key":"B21","first-page":"67","article-title":"Detection of parvovirus B19 markers in blood samples of donors","volume":"5","author":"Filatova","year":"2010","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"key":"B22","first-page":"443","article-title":"Seroprevalence of IgG antibodies against parvovirus B19 among blood donors from Santiago, Chile","volume":"135","author":"Gaggero","year":"2007","journal-title":"Rev Med Chil"},{"key":"B23","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1139\/w11-119","article-title":"Genotyping of human parvovirus B19 among Brazilian patients with hemoglobinopathies","volume":"58","author":"Slavov","year":"2012","journal-title":"Can J Microbiol"},{"key":"B24","first-page":"60","article-title":"Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province","volume":"20","author":"Wei","year":"2006","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/jmv.23358","article-title":"Molecular and phylogenetic analyses of human parvovirus B19 isolated from Brazilian patients with sickle cell disease and \u03b2-thalassemia major and healthy blood donors","volume":"84","author":"Slavov","year":"2012","journal-title":"J Med Virol"},{"key":"B26","first-page":"161","article-title":"Seroprevalence versus parvovirus B19 in blood donors","volume":"16","author":"Mu\u00f1oz","year":"1998","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"B27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0955-3886(97)00049-0","article-title":"Higher prevalence of parvovirus B19 in Belgian as compared to Tunisian blood donors: differential implications for prevention of transfusional transmission","volume":"18","author":"Leta\u00efef","year":"1997","journal-title":"Transfus Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1017\/S0950268804002389","article-title":"Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors","volume":"132","author":"Manaresi","year":"2004","journal-title":"Epidemiol Infect"},{"key":"B29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1046\/j.1423-0410.2002.00132.x","article-title":"Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques","volume":"82","author":"Saldanha","year":"2002","journal-title":"Vox Sang"},{"key":"B30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1423-0410.2009.01288.x","article-title":"Collaborative study to establish a replacement World Health Organization International Standard for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays","volume":"98","author":"Baylis","year":"2010","journal-title":"Vox Sang"},{"key":"B31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1128\/JCM.31.2.323-328.1993","article-title":"Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction","volume":"31","author":"McOmish","year":"1993","journal-title":"J Clin Microbiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/j.1365-2141.1995.tb05427.x","article-title":"Incidence of human parvovirus B19 DNA detection in blood donors","volume":"91","author":"Yoto","year":"1995","journal-title":"Br J Haematol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1423-0410.1998.7520097.x","article-title":"Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients","volume":"75","author":"Jordan","year":"1998","journal-title":"Vox Sang"},{"key":"B34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1046\/j.1423-0410.2003.00299.x","article-title":"Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins","volume":"84","author":"Thomas","year":"2003","journal-title":"Vox Sang"},{"key":"B35","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.transci.2005.06.002","article-title":"Prevalence of parvovirus B19 and hepatitis A virus in Portuguese blood donors","volume":"33","author":"Henriques","year":"2005","journal-title":"Transfus Apher Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1111\/j.1537-2995.2007.01443.x","article-title":"Blood donor screening for parvovirus B19 in Germany and Austria","volume":"47","author":"Schmidt","year":"2007","journal-title":"Transfusion"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1111\/j.1537-2995.2007.01341.x","article-title":"Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay","volume":"47","author":"Kleinman","year":"2007","journal-title":"Transfusion"},{"key":"B38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1423-0410.2010.01423.x","article-title":"Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003\u20132009","volume":"100","author":"Kooistra","year":"2011","journal-title":"Vox Sang"},{"key":"B39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3343\/kjlm.2010.30.1.58","article-title":"Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors","volume":"30","author":"Oh","year":"2010","journal-title":"Korean J Lab Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1111\/j.1537-2995.2011.03067.x","article-title":"The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers","volume":"51","author":"Ke","year":"2011","journal-title":"Transfusion"},{"key":"B41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000357650","article-title":"Parvovirus b19 infections and blood counts in blood donors","volume":"41","author":"Juhl","year":"2014","journal-title":"Transfus Med Hemother"},{"key":"B42","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/tme.12259","article-title":"The prevalence of hepatitis A virus and parvovirus B19 in source-plasma donors and whole blood donors in China","volume":"25","author":"Han","year":"2015","journal-title":"Transfus Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12288-015-0607-1","article-title":"Prevalence and viral load of human parvovirus B19 (B19V) among blood donors in South-East Brazil","volume":"32","author":"Slavov","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"key":"B44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000481444","article-title":"Experiences with the NAT testing for parvovirus B19 (B19V) and hepatitis A virus (HAV) in a five years period. Abstract","volume":"44","author":"Juhl","year":"2017","journal-title":"Transfus Med Hemother"},{"key":"B45","first-page":"A","article-title":"Parvovirus-B19-Infektionen: Sind es nur harmlose Ringelr\u00f6teln?","volume":"93","author":"Schleuning","year":"1996","journal-title":"Dtsch Arztebl"},{"key":"B46","first-page":"A","article-title":"Parvovirus B19: Ein Infektionserreger mit vielen Erkrankungsbildern","volume":"98","author":"Modrow","year":"2001","journal-title":"Dtsch Arztebl"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1017\/S0950268804002730","article-title":"Parvovirus B19 viraemia in Dutch blood donors","volume":"132","author":"Zaaijer","year":"2004","journal-title":"Epidemiol Infect"},{"key":"B48","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1046\/j.1537-2995.2001.41010130.x","article-title":"Parvovirus B19: implications for transfusion medicine. Summary of a workshop","volume":"41","author":"Brown","year":"2001","journal-title":"Transfusion"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1182\/blood-2005-03-1053","article-title":"Persistent B19 infection in immunocompetent individuals: implications for transfusion safety","volume":"106","author":"Lefr\u00e8re","year":"2005","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/j.1537-2995.2008.01704.x","article-title":"Persistent infection by human parvovirus B19 in qualified blood donors","volume":"48","author":"Matsukura","year":"2008","journal-title":"Transfusion"},{"key":"B51","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/vox.12162","article-title":"Persistence of parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors","volume":"107","author":"Juhl","year":"2014","journal-title":"Vox Sang"},{"key":"B52","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/jmv.2047","article-title":"Evidence for persistence of parvovirus B19 DNA in livers of adults","volume":"65","author":"Eis-H\u00fcbinger","year":"2001","journal-title":"J Med Virol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.1073\/pnas.0602259103","article-title":"Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue","volume":"103","author":"Norja","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1086\/648074","article-title":"Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis","volume":"49","author":"Kuethe","year":"2009","journal-title":"Clin Infect Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jcv.2013.07.007","article-title":"Low-level DNAemia of parvovirus B19 (genotypes 1\u20133) in adult transplant recipients is not associated with anaemia","volume":"58","author":"Plentz","year":"2013","journal-title":"J Clin Virol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jcv.2016.09.004","article-title":"Detection of parvovirus B19 DNA in blood: viruses or DNA remnants?","volume":"84","author":"Molenaar-de Backer","year":"2016","journal-title":"J Clin Virol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1365-3148.2007.00765.x","article-title":"Human erythrovirus B19 and blood transfusion \u2013 an update","volume":"17","author":"Parsyan","year":"2007","journal-title":"Transfus Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2450\/2014.0174.14","article-title":"Human parvovirus B19 and blood product safety: a tale of twenty years of improvements","volume":"13","author":"Marano","year":"2015","journal-title":"Blood Transfus"},{"key":"B59","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12985-015-0396-z","article-title":"Prevalence of human parvovirus B19 in Chinese plasma pools for manufacturing plasma derivatives","volume":"12","author":"Jia","year":"2015","journal-title":"Virol J"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/j.1537-2995.2012.03907.x","article-title":"Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening","volume":"53","author":"Soucie","year":"2013","journal-title":"Transfusion"},{"key":"B61","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1046\/j.1537-2995.1995.35996029163.x","article-title":"Transfusion-transmitted human parvovirus B19 infection in a thalassemic patient","volume":"35","author":"Zanella","year":"1995","journal-title":"Transfusion"},{"key":"B62","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1046\/j.1537-2995.1997.37997454023.x","article-title":"Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion","volume":"37","author":"Cohen","year":"1997","journal-title":"Transfusion"},{"key":"B63","unstructured":"SHOT-Report2016"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1111\/j.1537-2995.2010.02591.x","article-title":"Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples","volume":"50","author":"Yu","year":"2010","journal-title":"Transfusion"},{"key":"B65","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1537-2995.2010.02780.x","article-title":"Recipients potentially infected with parvovirus B19 by red blood cell products","volume":"51","author":"Hourfar","year":"2011","journal-title":"Transfusion"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1111\/j.1537-2995.2010.03047.x","article-title":"Symptomatic parvovirus B19 infection caused by blood component transfusion","volume":"51","author":"Satake","year":"2011","journal-title":"Transfusion"},{"key":"B67","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1423-0410.2010.01390.x","article-title":"Limits of sequencing and phylogenetic analysis to assess B19V transmission by single-donor blood component","volume":"100","author":"Servant-Delmas","year":"2011","journal-title":"Vox Sang"},{"key":"B68","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/vox.12295","article-title":"Look-back study on recipients of parvovirus B19 (B19V) DNA-positive blood components","volume":"109","author":"Juhl","year":"2015","journal-title":"Vox Sang"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1111\/trf.14088","article-title":"Persistent symptomatic parvovirus B19 infection with severe thrombocytopenia transmitted by red blood cell transfusion containing low parvovirus B19 DNA levels","volume":"57","author":"Nagaharu","year":"2017","journal-title":"Transfusion"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/S0140-6736(95)92950-9","article-title":"Screening of blood donors for human parvovirus B19","volume":"346","author":"Sato","year":"1995","journal-title":"Lancet"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/j.1537-2995.2012.03705.x","article-title":"Multicenter evaluation of a commercial multiplex polymerase chain reaction test for screening plasma donations for parvovirus B19 DNA and hepatitis A virus RNA","volume":"52","author":"Koppelman","year":"2012","journal-title":"Transfusion"},{"key":"B72","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/trf.13334","article-title":"Validation of new real-time polymerase chain reaction assays for detection of hepatitis A virus RNA and parvovirus B19 DNA","volume":"56","author":"Molenaar-de Backer","year":"2016","journal-title":"Transfusion"},{"key":"B73","first-page":"154","article-title":"Blood products and parvovirus B19","volume":"61","author":"Groeneveld","year":"2003","journal-title":"Neth J Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/j.1537-2995.2012.03573.x","article-title":"Inactivation and neutralization of parvovirus B19 genotype 3","volume":"52","author":"Bl\u00fcmel","year":"2012","journal-title":"Transfusion"},{"key":"B75","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-3148.2009.00931.x","article-title":"Effectiveness of nanofiltration in removing small non-enveloped viruses from three different plasma-derived products","volume":"19","author":"Menconi","year":"2009","journal-title":"Transfus Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000365646","article-title":"Pathogen inactivation technologies for cellular blood components: an update","volume":"41","author":"Schlenke","year":"2014","journal-title":"Transfus Med Hemother"},{"key":"B77","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000445195","article-title":"Parvovirus B19 passive transmission by transfusion of Intercept\u00ae blood system-treated platelet concentrate","volume":"43","author":"Gowland","year":"2016","journal-title":"Transfus Med Hemother"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2018.00004\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T20:09:11Z","timestamp":1603742951000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2018.00004\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":77,"alternative-id":["10.3389\/fmed.2018.00004"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2018.00004","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,1]]},"article-number":"4"}}